durvalumab consolidation in nsclc: the pacific trial
Published 5 years ago • 338 plays • Length 5:28Download video MP4
Download video MP3
Similar videos
-
1:01
impact of durvalumab as consolidation therapy in nsclc
-
1:45
enhancing benefit with durvalumab in nsclc after the pacific trial
-
6:22
refining which patients benefit from consolidation durvalumab for stage iii unresectable nsclc
-
3:22
locally advanced nsclc: durvalumab and the pacific trial
-
1:28
durvalumab as a consolidation therapy for locally advanced nsclc
-
5:13
effectively managing treatment with durvalumab
-
6:07
pacific trial: durvalumab following chemotherapy for stage iii nsclc
-
1:08
dr. bazhenova on the pacific trial with durvalumab in nsclc
-
8:36
pacific trial: durvalumab for stage 3 nsclc
-
2:52
examining recent pacific trial updates for durvalumab in locally advanced nsclc
-
4:25
durvalumab tolerability in non–small cell lung cancer
-
3:07
the use of durvalumab in locally advanced nsclc
-
1:07
pacific trial updates: durvalumab after chemotherapy in nsclc
-
4:16
nsclc management before and after the pacific trial
-
3:53
[lung]the role of durvalumab in patients with stage 3 lung cancer in a real hospital
-
4:16
reactions to the pacific trial in stage iii nsclc
-
1:24
durvalumab: the new standard of care for nsclc?
-
1:18
a study of chemotherapy with durvalumab and tremelimumab in nsclc
-
1:38
practical considerations for durvalumab in stage 3 nsclc